Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Edgewise Therapeutics, Inc. has filed 400 SEC EDGAR filings since 26 Sep 2019

SEC filing history

Showing 351-375 of 400 matching filings.

Per page
25
Current page
15
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 May 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
04 May 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92424

SCHEDULE 13D

Filing date
03 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92424

SCHEDULE 13D

Filing date
08 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92424

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92424

SC 13D

Filing date
31 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

FORM 8-K

Filing date
30 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Mar 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92424

SC 13G filing

Filing date
30 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-254792

FORM S-8

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-253923

424B4

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-253923

EFFECT filing

Filing date
25 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-254739

S-1MEF

Filing date
25 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .